They are substances that help neutralize free radicals and protect the cells from damage caused by free radicals
The global impact of diabetes is closely connected to the development of early insulin resistance, which stems from impaired signaling at the insulin receptor (INSR)
For any target anchor dose D (mg) and anchor mass M in the vial (GHK-Cu = 50 mg, BPC-157 = 10 mg): V water = V draw M D Worked example 3 mg GHK-Cu, 20-unit (0.2 mL) draw: V water = 0.2 mL 50 mg3 mg = 3.33 mL BAC water The GLOW Calculator above solves this for any anchor and draw volume
Yes, but they should be used at different times of day
When delivered systemically through injections, GHK-Cu works at a much deeper level, supporting cellular repair, tissue recovery, and long-term longevity from the inside out
Both have low side effect profiles when administered under supervision, but dosage and delivery method matter significantly